Serum alcohol dehydrogenase

A sensitive biomarker of ongoing graft function after liver transplantation

Naoki Shimojima, Motohide Shimazu, Haruhito Kikuchi, Shigeyuki Kawachi, Minoru Tanabe, Ken Hoshino, Go Wakabayashi, Yasuhide Morikawa, Masaki Kitajima

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Abstract: Alcohol dehydrogenase (ADH) is an enzyme specifically located in the cytoplasm of hepatocytes. The purpose of this study was to assess the potential usefulness of serum ADH activity as a biomarker of graft function following liver transplantation. Blood samples were obtained from 26 patients who underwent living-donor liver transplantation. In patients without any post-operative complication, serum ADH activity normalized at 2.9 ± 1.2 d. Values of serum ADH activity were remarkably elevated in patients with vascular complications, whereas they were only slightly elevated or remained within the reference range in patients with acute cellular rejections. In vascular complications, serum ADH activity peaked prior to elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and once the cause of damage was resolved, the values returned to reference range more quickly than did ALT and AST. In conclusion, monitoring serum ADH activity in addition to ALT and AST may provide more sensitive ongoing graft status and valuable information for the differential diagnosis of vascular complications and acute cellular rejection.

Original languageEnglish
Pages (from-to)498-501
Number of pages4
JournalClinical Transplantation
Volume21
Issue number4
DOIs
Publication statusPublished - 2007 Jul

Fingerprint

Alcohol Dehydrogenase
Liver Transplantation
Biomarkers
Transplants
Aspartate Aminotransferases
Serum
Alanine Transaminase
Blood Vessels
Reference Values
Living Donors
Hepatocytes
Cytoplasm
Differential Diagnosis
Enzymes

Keywords

  • Acute cellular rejection
  • Biomarker
  • Graft function
  • Post-operative complication
  • Vascular complication

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Serum alcohol dehydrogenase : A sensitive biomarker of ongoing graft function after liver transplantation. / Shimojima, Naoki; Shimazu, Motohide; Kikuchi, Haruhito; Kawachi, Shigeyuki; Tanabe, Minoru; Hoshino, Ken; Wakabayashi, Go; Morikawa, Yasuhide; Kitajima, Masaki.

In: Clinical Transplantation, Vol. 21, No. 4, 07.2007, p. 498-501.

Research output: Contribution to journalArticle

Shimojima, N, Shimazu, M, Kikuchi, H, Kawachi, S, Tanabe, M, Hoshino, K, Wakabayashi, G, Morikawa, Y & Kitajima, M 2007, 'Serum alcohol dehydrogenase: A sensitive biomarker of ongoing graft function after liver transplantation', Clinical Transplantation, vol. 21, no. 4, pp. 498-501. https://doi.org/10.1111/j.1399-0012.2007.00676.x
Shimojima, Naoki ; Shimazu, Motohide ; Kikuchi, Haruhito ; Kawachi, Shigeyuki ; Tanabe, Minoru ; Hoshino, Ken ; Wakabayashi, Go ; Morikawa, Yasuhide ; Kitajima, Masaki. / Serum alcohol dehydrogenase : A sensitive biomarker of ongoing graft function after liver transplantation. In: Clinical Transplantation. 2007 ; Vol. 21, No. 4. pp. 498-501.
@article{f04150b28b6d4b4ca0d6ac1d34e6e418,
title = "Serum alcohol dehydrogenase: A sensitive biomarker of ongoing graft function after liver transplantation",
abstract = "Abstract: Alcohol dehydrogenase (ADH) is an enzyme specifically located in the cytoplasm of hepatocytes. The purpose of this study was to assess the potential usefulness of serum ADH activity as a biomarker of graft function following liver transplantation. Blood samples were obtained from 26 patients who underwent living-donor liver transplantation. In patients without any post-operative complication, serum ADH activity normalized at 2.9 ± 1.2 d. Values of serum ADH activity were remarkably elevated in patients with vascular complications, whereas they were only slightly elevated or remained within the reference range in patients with acute cellular rejections. In vascular complications, serum ADH activity peaked prior to elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and once the cause of damage was resolved, the values returned to reference range more quickly than did ALT and AST. In conclusion, monitoring serum ADH activity in addition to ALT and AST may provide more sensitive ongoing graft status and valuable information for the differential diagnosis of vascular complications and acute cellular rejection.",
keywords = "Acute cellular rejection, Biomarker, Graft function, Post-operative complication, Vascular complication",
author = "Naoki Shimojima and Motohide Shimazu and Haruhito Kikuchi and Shigeyuki Kawachi and Minoru Tanabe and Ken Hoshino and Go Wakabayashi and Yasuhide Morikawa and Masaki Kitajima",
year = "2007",
month = "7",
doi = "10.1111/j.1399-0012.2007.00676.x",
language = "English",
volume = "21",
pages = "498--501",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Serum alcohol dehydrogenase

T2 - A sensitive biomarker of ongoing graft function after liver transplantation

AU - Shimojima, Naoki

AU - Shimazu, Motohide

AU - Kikuchi, Haruhito

AU - Kawachi, Shigeyuki

AU - Tanabe, Minoru

AU - Hoshino, Ken

AU - Wakabayashi, Go

AU - Morikawa, Yasuhide

AU - Kitajima, Masaki

PY - 2007/7

Y1 - 2007/7

N2 - Abstract: Alcohol dehydrogenase (ADH) is an enzyme specifically located in the cytoplasm of hepatocytes. The purpose of this study was to assess the potential usefulness of serum ADH activity as a biomarker of graft function following liver transplantation. Blood samples were obtained from 26 patients who underwent living-donor liver transplantation. In patients without any post-operative complication, serum ADH activity normalized at 2.9 ± 1.2 d. Values of serum ADH activity were remarkably elevated in patients with vascular complications, whereas they were only slightly elevated or remained within the reference range in patients with acute cellular rejections. In vascular complications, serum ADH activity peaked prior to elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and once the cause of damage was resolved, the values returned to reference range more quickly than did ALT and AST. In conclusion, monitoring serum ADH activity in addition to ALT and AST may provide more sensitive ongoing graft status and valuable information for the differential diagnosis of vascular complications and acute cellular rejection.

AB - Abstract: Alcohol dehydrogenase (ADH) is an enzyme specifically located in the cytoplasm of hepatocytes. The purpose of this study was to assess the potential usefulness of serum ADH activity as a biomarker of graft function following liver transplantation. Blood samples were obtained from 26 patients who underwent living-donor liver transplantation. In patients without any post-operative complication, serum ADH activity normalized at 2.9 ± 1.2 d. Values of serum ADH activity were remarkably elevated in patients with vascular complications, whereas they were only slightly elevated or remained within the reference range in patients with acute cellular rejections. In vascular complications, serum ADH activity peaked prior to elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and once the cause of damage was resolved, the values returned to reference range more quickly than did ALT and AST. In conclusion, monitoring serum ADH activity in addition to ALT and AST may provide more sensitive ongoing graft status and valuable information for the differential diagnosis of vascular complications and acute cellular rejection.

KW - Acute cellular rejection

KW - Biomarker

KW - Graft function

KW - Post-operative complication

KW - Vascular complication

UR - http://www.scopus.com/inward/record.url?scp=34547458693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547458693&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0012.2007.00676.x

DO - 10.1111/j.1399-0012.2007.00676.x

M3 - Article

VL - 21

SP - 498

EP - 501

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 4

ER -